Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × UNKNOWN × Genitourinary × Clear all

Phase

Status

Sponsor Class

OTHER 1658 INDUSTRY 502 NIH 254 NETWORK 82 FED 18 OTHER_GOV 13 UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 38 Breast 28 Thoracic 13 Head & Neck 10 Lymphoid 7 Gynecologic 3 CNS 3 Sarcoma 2 Genitourinary 2 Other solid neoplasm 1 Other neoplasm 1 NET 1 Endocrine 1

Conditions

Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

pyrotinib 1 Trastuzumab 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05318339 2022-04-08

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

ChineseAMS

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT01041482 2010-01-06

AGuo

ChineseAMS

Phase 2 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡